脂质修饰药物与双相情感障碍死亡率降低的关联:一项全国性队列研究
Pao-Huan Chen1, Shang-Ying Tsai1, Po-Yu Chen2
1Department of Psychiatry, Taipei Medical University Hospital, Taipei, Taiwan; Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Journal of affective disorders
|May 8, 2025
概括
脂质修饰药物显著降低双相情感障碍患者的全因,自然和自杀死亡率. 这些发现突出了超越心血管健康的潜在益处,为管理这一群体的死亡风险提供了新的途径.
科学领域:
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
- 流行病学 流行病学
背景情况:
- 双极性障碍与所有原因,自然和自杀死亡率的风险增加有关.
- 脂质修饰药物通常被处方,并可能影响情绪症状.
- 关于这些药物对双相情感障碍患者死亡率的影响的研究有限.
研究的目的:
- 调查双相情感障碍患者的脂质修饰药物和死亡风险 (全因,自然,自杀) 之间的关联.
- 评估不同类型的脂质修饰药物对死亡结果的具体影响.
主要方法:
- 一项利用台湾国家健康保险研究数据库 (2001-2022) 进行的国家队列研究.
- 包括32479名被诊断患有双相情感障碍的患者,记录6800例死亡.
- 使用多变量考克斯回归与时间依赖模型计算标准化死亡率 (SMR) 和危险率 (HR).
主要成果:
- 双极性队列在所有原因 (6.36),自然 (5.28) 和自杀 (29.07) 死亡率上表现出显著更高的SMR.
- 脂质修饰药物与所有原因 (aHR=0.38),自然 (aHR=0.41) 和自杀死亡率 (aHR=0.41) 在5年内显著减少有关.
- 特定类型的脂质修饰药物 - - 类药物和纤维化药物 - - 与降低全因,自然和自杀死亡率的风险有关.
结论:
- 脂质修饰药物对双相情感障碍患者的自然,自杀和全因死亡率表现出保护作用.
- 这些发现表明,除了降脂效果之外,脂质修饰药物的潜在益处是多益的.
- 对这些药物在双相情感障碍中更广泛的治疗应用的进一步研究是有必要的.
相关概念视频
01:24Mania and Antimanic Drugs: Overview
103
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
103
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
465
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
465
01:23Antidepressant Drugs: MAOIs and Other Agents
163
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
163
01:28Drug Therapy
30
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
30
01:30Bipolar Disorder
37
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
37
01:26Psychosis: Goals of Pharmacotherapy
95
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
95